Antibiotic Treatment for Wound Infections
For wound infections, empiric antibiotic therapy should be selected based on infection severity, with amoxicillin-clavulanate, cloxacillin, or cephalexin as first-line options for mild infections, while moderate to severe infections require broader coverage with combination therapy such as vancomycin plus piperacillin-tazobactam or ceftriaxone plus metronidazole.
Classification of Wound Infections
Wound infections can be classified into three main categories:
- Non-purulent infections: Cellulitis, erysipelas
- Purulent infections: Abscesses, furuncles, carbuncles
- Necrotizing infections: Fasciitis, myonecrosis
Antibiotic Selection Based on Severity
Mild Infections
For mild superficial wound infections:
- Amoxicillin-clavulanate 875/125 mg twice daily orally for 5-7 days
- Cloxacillin 500 mg four times daily for 5-7 days
- Cephalexin 500 mg four times daily for 5-7 days
For patients with penicillin allergy 2:
- Clindamycin 300-450 mg orally three times daily for 7-10 days
- Doxycycline 100 mg twice daily for 5-7 days
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 DS tablets twice daily for 5-7 days
Moderate to Severe Infections
For moderate to severe wound infections 1:
First-line combination therapy:
- Vancomycin plus piperacillin-tazobactam
- Ceftriaxone plus metronidazole
- Ampicillin-sulbactam
For suspected MRSA infections 1, 2:
- Add vancomycin 15-20 mg/kg IV every 8-12 hours
- Linezolid 600 mg IV/PO twice daily
- Daptomycin 4 mg/kg IV once daily
Necrotizing Fasciitis
For necrotizing fasciitis, urgent surgical debridement plus 1:
- Vancomycin plus piperacillin-tazobactam or a carbapenem
- Clindamycin plus piperacillin-tazobactam (with or without vancomycin)
- Ceftriaxone plus metronidazole (with or without vancomycin)
Pathogen-Specific Treatment
For specific pathogens, targeted therapy includes 1:
- Streptococcus: Penicillin plus clindamycin
- Staphylococcus aureus: Nafcillin, oxacillin, cefazolin, or clindamycin
- Clostridium species: Clindamycin plus penicillin
- Aeromonas hydrophila: Doxycycline plus ciprofloxacin or ceftriaxone
- Vibrio vulnificus: Doxycycline plus ceftriaxone or cefotaxime
Special Considerations
Animal and Human Bites
For animal bites 1:
- Amoxicillin-clavulanate (oral)
- Ampicillin-sulbactam, piperacillin-tazobactam (IV)
For human bites 1:
- Amoxicillin-clavulanate
- Ampicillin-sulbactam
Diabetic Foot Infections
For diabetic foot infections 1:
Mild infections:
- Dicloxacillin, clindamycin, cephalexin, levofloxacin, amoxicillin-clavulanate, or doxycycline
Moderate to severe infections:
- Levofloxacin, cefoxitin, ceftriaxone, ampicillin-sulbactam, ertapenem
- For suspected MRSA: Add linezolid, daptomycin, or vancomycin
For potential Pseudomonas aeruginosa infection:
- Piperacillin-tazobactam, ceftazidime, cefepime, or carbapenems
Duration of Therapy
The duration of antibiotic therapy depends on the severity of infection 1, 2:
- Mild infections: 5-7 days
- Moderate infections: 7-10 days
- Severe infections: 10-14 days
- Necrotizing infections: 2-3 weeks
Important Considerations and Pitfalls
Do not treat clinically uninfected wounds with antibiotics 1
Appropriate wound care is essential alongside antibiotic therapy 1:
- Debridement of necrotic tissue
- Drainage of purulent collections
- Wound cleansing
Obtain cultures before starting antibiotics when possible, especially for moderate to severe infections 1
Switch from IV to oral therapy when the patient shows clinical improvement and can tolerate oral medications 1
Avoid overuse of broad-spectrum antibiotics to prevent antimicrobial resistance 2, 3
Address predisposing factors such as edema, venous insufficiency, or tinea pedis to prevent recurrence 2
Consider prophylactic antibiotics for highly contaminated traumatic wounds 1, 4:
- Cephalexin 500 mg four times daily for 2 days is as effective as a 5-day regimen
Evidence Quality and Considerations
The recommendations from the Infectious Diseases Society of America (IDSA) provide the most comprehensive and recent guidelines for treating wound infections 1. These guidelines emphasize tailoring antibiotic therapy based on infection severity, likely pathogens, and patient factors.
Recent studies support shorter courses of antibiotics for contaminated traumatic wounds, with 2-day prophylactic regimens showing similar efficacy to 5-day regimens 4. This approach helps reduce antibiotic overuse while maintaining effective infection prevention.
For linezolid, FDA data shows high cure rates (90%) for complicated skin and skin structure infections, making it an effective option for MRSA infections 5.
The WHO's Essential Medicines list provides globally applicable recommendations for first-line and second-line antibiotics for various wound infections, supporting a structured approach to antibiotic selection 1.